Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Long-term research avoids spurious and misleading trends in sustainability attributes of no-till.

Cusser S, Bahlai C, Swinton SM, Robertson GP, Haddad NM.

Glob Chang Biol. 2020 Mar 16. doi: 10.1111/gcb.15080. [Epub ahead of print]

PMID:
32175629
2.

Empirical Evidence for the Potential Climate Benefits of Decarbonizing Light Vehicle Transport in the U.S. with Bioenergy from Purpose-Grown Biomass with and without BECCS.

Gelfand I, Hamilton SK, Kravchenko AN, Jackson RD, Thelen KD, Robertson GP.

Environ Sci Technol. 2020 Mar 3;54(5):2961-2974. doi: 10.1021/acs.est.9b07019. Epub 2020 Feb 13.

PMID:
32052964
3.

The role of exosomes in metastasis and progression of melanoma.

Gowda R, Robertson BM, Iyer S, Barry J, Dinavahi SS, Robertson GP.

Cancer Treat Rev. 2020 Apr;85:101975. doi: 10.1016/j.ctrv.2020.101975. Epub 2020 Jan 22. Review.

PMID:
32050108
4.

Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.

Dinavahi SS, Gowda R, Bazewicz CG, Battu MB, Lin JM, Chitren RJ, Pandey MK, Amin S, Robertson GP, Gowda K.

Eur J Med Chem. 2020 Feb 1;187:111962. doi: 10.1016/j.ejmech.2019.111962. Epub 2019 Dec 12.

PMID:
31887569
5.

Silver-Catalyzed Enantioselective Mannich Reaction of Diazoacetate Esters with N-Boc Aldimines.

Robertson GP, Farley AJM, Dixon DJ.

J Org Chem. 2020 Feb 21;85(4):2785-2792. doi: 10.1021/acs.joc.9b03177. Epub 2020 Jan 8.

PMID:
31870157
6.

Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent.

Dinavahi SS, Gowda R, Gowda K, Bazewicz CG, Chirasani VR, Battu MB, Berg A, Dokholyan NV, Amin S, Robertson GP.

Mol Cancer Ther. 2020 Feb;19(2):447-459. doi: 10.1158/1535-7163.MCT-19-0360. Epub 2019 Nov 21.

PMID:
31754071
7.

Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics.

Dinavahi SS, Bazewicz CG, Gowda R, Robertson GP.

Trends Pharmacol Sci. 2019 Oct;40(10):774-789. doi: 10.1016/j.tips.2019.08.002. Epub 2019 Sep 9. Review.

PMID:
31515079
8.

Author Correction: Microbial spatial footprint as a driver of soil carbon stabilization.

Kravchenko AN, Guber AK, Razavi BS, Koestel J, Quigley MY, Robertson GP, Kuzyakov Y.

Nat Commun. 2019 Sep 5;10(1):4103. doi: 10.1038/s41467-019-12000-3.

9.

Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.

Buj R, Chen CW, Dahl ES, Leon KE, Kuskovsky R, Maglakelidze N, Navaratnarajah M, Zhang G, Doan MT, Jiang H, Zaleski M, Kutzler L, Lacko H, Lu Y, Mills GB, Gowda R, Robertson GP, Warrick JI, Herlyn M, Imamura Y, Kimball SR, DeGraff DJ, Snyder NW, Aird KM.

Cell Rep. 2019 Aug 20;28(8):1971-1980.e8. doi: 10.1016/j.celrep.2019.07.084.

10.

Microbial spatial footprint as a driver of soil carbon stabilization.

Kravchenko AN, Guber AK, Razavi BS, Koestel J, Quigley MY, Robertson GP, Kuzyakov Y.

Nat Commun. 2019 Jul 16;10(1):3121. doi: 10.1038/s41467-019-11057-4. Erratum in: Nat Commun. 2019 Sep 5;10(1):4103.

11.

Yield stability analysis reveals sources of large-scale nitrogen loss from the US Midwest.

Basso B, Shuai G, Zhang J, Robertson GP.

Sci Rep. 2019 Apr 8;9(1):5774. doi: 10.1038/s41598-019-42271-1.

12.

Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity.

Kokolus KM, Haley JS, Koubek EJ, Gowda R, Dinavahi SS, Sharma A, Claxton DF, Helm KF, Drabick JJ, Robertson GP, Neighbors JD, Hohl RJ, Schell TD.

Oncoimmunology. 2018 Nov 11;8(2):e1539614. doi: 10.1080/2162402X.2018.1539614. eCollection 2019.

13.

Advancing the Sustainability of US Agriculture through Long-Term Research.

Kleinman PJA, Spiegal S, Rigby JR, Goslee SC, Baker JM, Bestelmeyer BT, Boughton RK, Bryant RB, Cavigelli MA, Derner JD, Duncan EW, Goodrich DC, Huggins DR, King KW, Liebig MA, Locke MA, Mirsky SB, Moglen GE, Moorman TB, Pierson FB, Robertson GP, Sadler EJ, Shortle JS, Steiner JL, Strickland TC, Swain HM, Tsegaye T, Williams MR, Walthall CL.

J Environ Qual. 2018 Nov;47(6):1412-1425. doi: 10.2134/jeq2018.05.0171.

PMID:
30512071
14.

Loss of miR-155 upregulates WEE1 in metastatic melanoma.

DiSano JA, Huffnagle I, Gowda R, Spiegelman VS, Robertson GP, Pameijer CR.

Melanoma Res. 2019 Apr;29(2):216-219. doi: 10.1097/CMR.0000000000000545.

PMID:
30499870
15.

Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancer.

Bazewicz CG, Dinavahi SS, Schell TD, Robertson GP.

Immunology. 2019 Jan;156(1):47-55. doi: 10.1111/imm.13016. Epub 2018 Nov 22. Review.

16.

The greenhouse gas cost of agricultural intensification with groundwater irrigation in a Midwest U.S. row cropping system.

McGill BM, Hamilton SK, Millar N, Robertson GP.

Glob Chang Biol. 2018 Dec;24(12):5948-5960. doi: 10.1111/gcb.14472. Epub 2018 Oct 26.

PMID:
30295393
17.

Perennialization and Cover Cropping Mitigate Soil Carbon Loss from Residue Harvesting.

Jones CD, Oates LG, Robertson GP, Izaurralde RC.

J Environ Qual. 2018 Jul;47(4):710-717. doi: 10.2134/jeq2017.04.0177.

PMID:
30025060
18.

Correction: eEF-2 kinase is a critical regulator of Warbrug effect through controlling PP2A-A synthesis.

Cheng Y, Ren X, Yuan Y, Shan Y, Li L, Chen X, Zhang L, Takahashi Y, Yang JW, Han B, Liao J, Li Y, Harvey H, Ryazanov A, Robertson GP, Wan G, Liu D, Chen AF, Tao Y, Yang JM.

Oncogene. 2018 Aug;37(33):4633-4634. doi: 10.1038/s41388-018-0322-0.

PMID:
29973686
19.

Legacy effects of land use on soil nitrous oxide emissions in annual crop and perennial grassland ecosystems.

Abraha M, Gelfand I, Hamilton SK, Chen J, Robertson GP.

Ecol Appl. 2018 Jul;28(5):1362-1369. doi: 10.1002/eap.1745. Epub 2018 Jun 1.

PMID:
29856901
20.

Associative nitrogen fixation (ANF) in switchgrass (Panicum virgatum) across a nitrogen input gradient.

Roley SS, Duncan DS, Liang D, Garoutte A, Jackson RD, Tiedje JM, Robertson GP.

PLoS One. 2018 Jun 1;13(6):e0197320. doi: 10.1371/journal.pone.0197320. eCollection 2018.

21.

Measuring Spin Relaxation Rates Using Satellite Exchange NMR Spectroscopy.

Robertson GP, Odell B, Kuprov I, Dixon DJ, Claridge TDW.

Angew Chem Int Ed Engl. 2018 Jun 18;57(25):7498-7502. doi: 10.1002/anie.201801322. Epub 2018 Apr 14.

PMID:
29575317
22.

Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Gowda R, Dinavahi SS, Iyer S, Banerjee S, Neves RI, Pameijer CR, Robertson GP.

Nanomedicine. 2018 Apr;14(3):863-873. doi: 10.1016/j.nano.2017.12.020. Epub 2018 Jan 6.

23.

Moving Synergistically Acting Drug Combinations to the Clinic by Comparing Sequential versus Simultaneous Drug Administrations.

Dinavahi SS, Noory MA, Gowda R, Drabick JJ, Berg A, Neves RI, Robertson GP.

Mol Pharmacol. 2018 Mar;93(3):190-196. doi: 10.1124/mol.117.110759. Epub 2017 Dec 14.

24.

Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.

Taylor MD, Bollt O, Iyer SC, Robertson GP.

Clin Exp Metastasis. 2018 Feb;35(1-2):15-23. doi: 10.1007/s10585-017-9869-3. Epub 2017 Dec 7.

PMID:
29218652
25.

Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.

Borland MG, Yao PL, Kehres EM, Lee C, Pritzlaff AM, Ola E, Wagner AL, Shannon BE, Albrecht PP, Zhu B, Kang BH, Robertson GP, Gonzalez FJ, Peters JM.

Toxicol Sci. 2017 Oct 1;159(2):436-448. doi: 10.1093/toxsci/kfx147.

26.

Identification of WEE1 as a target to make AKT inhibition more effective in melanoma.

Kuzu OF, Gowda R, Sharma A, Noory MA, Kardos G, Madhunapantula SV, Drabick JJ, Robertson GP.

Cancer Biol Ther. 2018 Jan 2;19(1):53-62. doi: 10.1080/15384047.2017.1360446. Epub 2017 Nov 30.

27.

Improving pharmacological targeting of AKT in melanoma.

Kuzu OF, Gowda R, Sharma A, Noory MA, Dinavahi SS, Kardos G, Drabick JJ, Robertson GP.

Cancer Lett. 2017 Sep 28;404:29-36. doi: 10.1016/j.canlet.2017.07.001. Epub 2017 Jul 11.

PMID:
28705772
28.

Modulating cancer cell survival by targeting intracellular cholesterol transport.

Kuzu OF, Gowda R, Noory MA, Robertson GP.

Br J Cancer. 2017 Aug 8;117(4):513-524. doi: 10.1038/bjc.2017.200. Epub 2017 Jul 11.

29.

Targeting cholesterol transport in circulating melanoma cells to inhibit metastasis.

Chen YC, Gowda R, Newswanger RK, Leibich P, Fell B, Rosenberg G, Robertson GP.

Pigment Cell Melanoma Res. 2017 Jan;30(6):541-552. doi: 10.1111/pcmr.12614. Epub 2017 Oct 15.

PMID:
28685959
30.

Cellulosic biofuel contributions to a sustainable energy future: Choices and outcomes.

Robertson GP, Hamilton SK, Barham BL, Dale BE, Izaurralde RC, Jackson RD, Landis DA, Swinton SM, Thelen KD, Tiedje JM.

Science. 2017 Jun 30;356(6345). pii: eaal2324. doi: 10.1126/science.aal2324. Review.

PMID:
28663443
31.

Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.

Gowda R, Inamdar GS, Kuzu O, Dinavahi SS, Krzeminski J, Battu MB, Voleti SR, Amin S, Robertson GP.

Oncotarget. 2017 Apr 25;8(17):28260-28277. doi: 10.18632/oncotarget.16002.

32.

Future of circulating tumor cells in the melanoma clinical and research laboratory settings.

De Souza LM, Robertson BM, Robertson GP.

Cancer Lett. 2017 Apr 28;392:60-70. doi: 10.1016/j.canlet.2017.01.023. Epub 2017 Feb 2. Review.

PMID:
28163189
33.

Field-scale experiments reveal persistent yield gaps in low-input and organic cropping systems.

Kravchenko AN, Snapp SS, Robertson GP.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):926-931. doi: 10.1073/pnas.1612311114. Epub 2017 Jan 17.

34.

Targeting protein kinase-b3 (akt3) signaling in melanoma.

Madhunapantula SV, Robertson GP.

Expert Opin Ther Targets. 2017 Mar;21(3):273-290. doi: 10.1080/14728222.2017.1279147. Epub 2017 Jan 16. Review.

PMID:
28064546
35.

Effect of lysosomotropic molecules on cellular homeostasis.

Kuzu OF, Toprak M, Noory MA, Robertson GP.

Pharmacol Res. 2017 Mar;117:177-184. doi: 10.1016/j.phrs.2016.12.021. Epub 2016 Dec 23. Review.

PMID:
28025106
36.

Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.

Gowda R, Kardos G, Sharma A, Singh S, Robertson GP.

Mol Cancer Ther. 2017 Mar;16(3):440-452. doi: 10.1158/1535-7163.MCT-16-0285. Epub 2016 Dec 21.

37.

Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.

Gowda R, Sharma A, Robertson GP.

Cancer Lett. 2017 Jan 28;385:243-250. doi: 10.1016/j.canlet.2016.10.016. Epub 2016 Oct 18.

PMID:
27769779
38.

Long-term nitrous oxide fluxes in annual and perennial agricultural and unmanaged ecosystems in the upper Midwest USA.

Gelfand I, Shcherbak I, Millar N, Kravchenko AN, Robertson GP.

Glob Chang Biol. 2016 Nov;22(11):3594-3607. doi: 10.1111/gcb.13426. Epub 2016 Aug 11.

PMID:
27510313
39.

The Role of Cholesterol in Cancer.

Kuzu OF, Noory MA, Robertson GP.

Cancer Res. 2016 Apr 15;76(8):2063-70. doi: 10.1158/0008-5472.CAN-15-2613. Epub 2016 Apr 5. Review.

40.

eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Cheng Y, Ren X, Yuan Y, Shan Y, Li L, Chen X, Zhang L, Takahashi Y, Yang JW, Han B, Liao J, Li Y, Harvey H, Ryazanov A, Robertson GP, Wan G, Liu D, Chen AF, Tao Y, Yang JM.

Oncogene. 2016 Dec 8;35(49):6293-6308. doi: 10.1038/onc.2016.166. Epub 2016 May 16. Erratum in: Oncogene. 2018 Aug;37(33):4633-4634.

PMID:
27181208
41.

Climate-smart soils.

Paustian K, Lehmann J, Ogle S, Reay D, Robertson GP, Smith P.

Nature. 2016 Apr 7;532(7597):49-57. doi: 10.1038/nature17174.

PMID:
27078564
42.

Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy.

Brys AK, Gowda R, Loriaux DB, Robertson GP, Mosca PJ.

Biotechnol Adv. 2016 Sep-Oct;34(5):565-577. doi: 10.1016/j.biotechadv.2016.01.004. Epub 2016 Jan 28. Review.

PMID:
26826558
43.

Topography Mediates the Influence of Cover Crops on Soil Nitrate Levels in Row Crop Agricultural Systems.

Ladoni M, Kravchenko AN, Robertson GP.

PLoS One. 2015 Nov 23;10(11):e0143358. doi: 10.1371/journal.pone.0143358. eCollection 2015.

44.

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

Song C, Gowda C, Pan X, Ding Y, Tong Y, Tan BH, Wang H, Muthusami S, Ge Z, Sachdev M, Amin SG, Desai D, Gowda K, Gowda R, Robertson GP, Schjerven H, Muschen M, Payne KJ, Dovat S.

Blood. 2015 Oct 8;126(15):1813-22. doi: 10.1182/blood-2015-06-651505. Epub 2015 Jul 28.

45.

Therapeutic interventions to disrupt the protein synthetic machinery in melanoma.

Kardos GR, Robertson GP.

Pigment Cell Melanoma Res. 2015 Sep;28(5):501-19. doi: 10.1111/pcmr.12391. Review.

46.

Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.

Kardos GR, Wastyk HC, Robertson GP.

Mol Cancer Res. 2015 Oct;13(10):1408-20. doi: 10.1158/1541-7786.MCR-15-0048. Epub 2015 Jun 16.

47.

Can Impacts of Climate Change and Agricultural Adaptation Strategies Be Accurately Quantified if Crop Models Are Annually Re-Initialized?

Basso B, Hyndman DW, Kendall AD, Grace PR, Robertson GP.

PLoS One. 2015 Jun 4;10(6):e0127333. doi: 10.1371/journal.pone.0127333. eCollection 2015.

48.

A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activity.

Sadashiva MP, Gowda R, Wu X, Inamdar GS, Kuzu OF, Rangappa KS, Robertson GP, Gowda DC.

Exp Parasitol. 2015 Aug;155:68-73. doi: 10.1016/j.exppara.2015.05.002. Epub 2015 May 14.

49.

Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma.

Gowda R, Madhunapantula SV, Sharma A, Kuzu OF, Robertson GP.

Mol Cancer Ther. 2014 Oct;13(10):2328-40. doi: 10.1158/1535-7163.MCT-14-0357. Epub 2014 Jul 31.

50.

Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy.

Gowda R, Jones NR, Banerjee S, Robertson GP.

J Nanomed Nanotechnol. 2013 Dec;4(6). pii: 184.

Supplemental Content

Loading ...
Support Center